Analysts Bullish on COMPASS Pathways plc (CMPS) Following Psychedelics Symposium and Model Updates
TheFly reported on February 14 that LifeSci Capital was bullish on CMPS, as the firm initiated coverage on the stock with a Buy rating and a $15 price target.





